Demographic Shifts And NIH Funding Will Unlock Biomedical Potential
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 1 Analyst
Published
15 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$3.00
82.4% undervalued intrinsic discount15 Aug
US$0.53
1Y
-82.1%7D
10.4%